$3.55
-0.62-14.87%
Upstream Bio Inc
UPBNASDAQ
Upstream Bio (UPB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.76 | $-0.76 | $-0.71 | $-0.78 |
| Actual | $-0.73 | $-0.75 | $-0.78 | $-0.63 |
| Surprise | +3.95% | +1.32% | -9.86% | +19.2% |
| Revenue | ||||
| Estimate | $435800 | $379736 | $600942 | $694080 |
| Actual | $773000 | $1.0M | $668000 | $683000 |
| Surprise | +77.4% | +172.3% | +11.2% | -1.60% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.72 | $-0.71 | $-0.68 | $-0.69 |
| Revenue | ||||
| Consensus | $540232 | $544856 | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.73 | $-0.76 | 3.95 % |
| Q1 | May 13, 2026 | $-0.75 | $-0.76 | 1.32 % |
| Q4 | Mar 26, 2026 | $-0.78 | $-0.71 | -9.86 % |
| Q3 | Nov 5, 2025 | $-0.63 | $-0.78 | 19.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $773.00K | $435.80K | 77.4 % |
| Q1 | May 13, 2026 | $1.03M | $379.74K | 172.3 % |
| Q4 | Mar 26, 2026 | $668.00K | $600.94K | 11.2 % |
| Q3 | Nov 5, 2025 | $683.00K | $694.08K | -1.60 % |
